Abstract：
BACKGROUND: Coronary heart disease (CHD) is the most prevalent type of cardiovascular disease in Iran. This study aims to investigate the estimation and determinants of direct hospitalisation cost for patients with CHD in Iranian hospitals.
METHODS: We identified patients with CHD in Iran in 2019-2020. Data were gathered from the Iran Health Insurance Organisation information systems and the Ministry of Health and Medical Education. This was a cross-sectional prevalence-based study. Generalised linear models were used to find the determinants of hospitalisation cost for patients with CHD. A total of 86 834 patients suffering from CHD were studied.
RESULTS: Mean hospitalisation cost per CHD patient was US$382.90±US$500.72 while the mean daily hospitalisation cost per CHD patient was US$89.71±US$89.99. In-hospital mortality of CHD was 2.52%. Hospitalisation accommodation and medications had the highest share of hospitalisation costs (25.59% and 22.63%, respectively). Men spent 1.12 (95% CI 1.11 to 1.13) times more on hospitalisation costs compared with women, and individuals aged 60 to 69 had hospitalisation costs 1.04 (95% CI 1.02 to 1.06) times higher than those in the 0-49 age range. Patients insured by the Iranian Fund have significantly higher costs 1.17 (95% CI 1.14 to 1.19) than the Rural fund. Hospitalisation costs for patients with CHD who received surgery and angiography were significantly 2.36 (95% CI 2.30 to 2.43) times higher than for patients who did not undergo surgery and angiography.
CONCLUSIONS: Applying CHD prevention strategies for men and the middle-aged population (50-70 years) is strongly recommended. Prudent use and prescribing of medications will be helpful to reduce hospitalisation cost.
METHODS: We identified patients with CHD in Iran in 2019-2020. Data were gathered from the Iran Health Insurance Organisation information systems and the Ministry of Health and Medical Education. This was a cross-sectional prevalence-based study. Generalised linear models were used to find the determinants of hospitalisation cost for patients with CHD. A total of 86 834 patients suffering from CHD were studied.
RESULTS: Mean hospitalisation cost per CHD patient was US$382.90±US$500.72 while the mean daily hospitalisation cost per CHD patient was US$89.71±US$89.99. In-hospital mortality of CHD was 2.52%. Hospitalisation accommodation and medications had the highest share of hospitalisation costs (25.59% and 22.63%, respectively). Men spent 1.12 (95% CI 1.11 to 1.13) times more on hospitalisation costs compared with women, and individuals aged 60 to 69 had hospitalisation costs 1.04 (95% CI 1.02 to 1.06) times higher than those in the 0-49 age range. Patients insured by the Iranian Fund have significantly higher costs 1.17 (95% CI 1.14 to 1.19) than the Rural fund. Hospitalisation costs for patients with CHD who received surgery and angiography were significantly 2.36 (95% CI 2.30 to 2.43) times higher than for patients who did not undergo surgery and angiography.
CONCLUSIONS: Applying CHD prevention strategies for men and the middle-aged population (50-70 years) is strongly recommended. Prudent use and prescribing of medications will be helpful to reduce hospitalisation cost.
摘要：
背景：冠心病（CHD）是伊朗最常见的心血管疾病。本研究旨在调查伊朗医院冠心病患者直接住院费用的估计和决定因素。
方法：我们在2019-2020年确定了伊朗的冠心病患者。数据来自伊朗健康保险组织信息系统和卫生与医学教育部。这是一项基于横断面患病率的研究。使用广义线性模型来找到冠心病患者住院费用的决定因素。共研究了86834例冠心病患者。
结果：每位冠心病患者的平均住院费用为382.90美元±500.72美元，每位冠心病患者的平均每日住院费用为89.71美元±89.99美元。冠心病住院死亡率为2.52%。住院住宿和药物在住院费用中所占比例最高(分别为25.59%和22.63%，分别)。男性的住院费用是女性的1.12倍（95%CI1.11至1.13），60~69岁人群的住院费用比0~49岁人群高1.04倍(95%CI1.02~1.06).由伊朗基金承保的患者的费用比农村基金高得多，为1.17（95％CI1.14至1.19）。接受手术和血管造影的冠心病患者的住院费用比没有接受手术和血管造影的患者高2.36倍（95％CI2.30至2.43）。
结论：强烈建议对男性和中年人（50-70岁）采用冠心病预防策略。谨慎使用和处方药物将有助于降低住院成本。
方法：我们在2019-2020年确定了伊朗的冠心病患者。数据来自伊朗健康保险组织信息系统和卫生与医学教育部。这是一项基于横断面患病率的研究。使用广义线性模型来找到冠心病患者住院费用的决定因素。共研究了86834例冠心病患者。
结果：每位冠心病患者的平均住院费用为382.90美元±500.72美元，每位冠心病患者的平均每日住院费用为89.71美元±89.99美元。冠心病住院死亡率为2.52%。住院住宿和药物在住院费用中所占比例最高(分别为25.59%和22.63%，分别)。男性的住院费用是女性的1.12倍（95%CI1.11至1.13），60~69岁人群的住院费用比0~49岁人群高1.04倍(95%CI1.02~1.06).由伊朗基金承保的患者的费用比农村基金高得多，为1.17（95％CI1.14至1.19）。接受手术和血管造影的冠心病患者的住院费用比没有接受手术和血管造影的患者高2.36倍（95％CI2.30至2.43）。
结论：强烈建议对男性和中年人（50-70岁）采用冠心病预防策略。谨慎使用和处方药物将有助于降低住院成本。
